During the past decade, Diakonissen-Stiftungs-Krankenhaus Speyer conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diakonissen-Stiftungs-Krankenhaus Speyer" #1 sponsor was "Biotronik AG" with 1 trials, followed by "Daiichi Sankyo, Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Essity Hygiene and Health AB" with 1 trials sponsored and "Institut für Klinisch-Kardiovaskuläre Forschung GmbH" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diakonissen-Stiftungs-Krankenhaus Speyer" #1 collaborator was "Smerud Medical Research Germany Ltd" with 1 trials as a collaborator and "Technical University of Munich" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Diakonissen-Stiftungs-Krankenhaus Speyer" are "Atrial Fibrillation" (1 trials), "Breast Neoplasms" (1 trials), "Colorectal Neoplasms" (1 trials), "Complex Lesions of the Superficial Femoral Artery" (1 trials) and "De Novo and Re-stenosed Coronary Artery Lesions" (1 trials). Many other conditions were trialed in "Diakonissen-Stiftungs-Krankenhaus Speyer" in a lesser frequency.

Most popular intervention types in "Diakonissen-Stiftungs-Krankenhaus Speyer" are "Device" (2 trials), "Drug" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anastrozole" (1 trials), "Best endovascular treatment or Best surgical treatment" (1 trials), "Edoxaban" (1 trials), "Exemestane" (1 trials) and "Imlunestrant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diakonissen-Stiftungs-Krankenhaus Speyer" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Diakonissen-Stiftungs-Krankenhaus Speyer". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Diakonissen-Stiftungs-Krankenhaus Speyer, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Diakonissen-Stiftungs-Krankenhaus Speyer, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".